Haptena

1 known investors

Haptena Therapeutics is a biotech company developing next-generation immunotherapies for oncogene-driven, genetically defined cancers, starting with KRAS-driven tumors. It combines targeted therapy precision with immune-based approaches to create more durable treatment options for patients with difficult-to-treat cancers.